Explore all of ul.com

The US Food and Drug Administration (FDA) has issued a Notification on Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular-Related Imagery; Guidance for Industry; Availability.

This notification on the guidance document contains the reminder for safe use of nonprescription (also referred to as over-the-counter or OTC) aspirin drug products to include a statement that reminds consumers to talk to their health care provider before using aspirin for their heart.

The guidance was released on November 7, 2017.



Subscribe to Newsletter

The CRS monthly Newsletter focuses on the latest initiatives, insights and information for manufacturers and retailers across industries.